Hepatocellular carcinoma: Difference between revisions
Line 35: | Line 35: | ||
==Treatment== | ==Treatment== | ||
[[Hepatocellular carcinoma medical therapy|Medical Therapy]] | [[Hepatocellular carcinoma surgery|Surgery]] | [[Hepatocellular carcinoma medical therapy|Medical Therapy]] | [[Hepatocellular carcinoma surgery|Surgery]] | [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | ||
Line 44: | Line 44: | ||
'''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | '''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | ||
'''Prevention:''' | '''Prevention:''' | ||
==Resources== | ==Resources== |
Revision as of 14:40, 10 September 2015
Hepatocellular carcinoma | |
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical Therapy | Surgery | Primary prevention | Secondary prevention
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol
- Hydroxyprogesterone caproate
Surgery: Liver transplant | Surgical resection | Cryosurgery
Prevention:
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology